Mimedx EPS MDXG
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Sep 30, 2026
- −$0.13
- Latest quarter, Q3 FY26
- −$0.06
- −155% on a year earlier
- Fiscal year 2025
- $0.32
- +14% on the year before
Mimedx's earnings per share was −$0.13 over the twelve months to Sep 30, 2026, down 148% on a year earlier.
In its latest quarter, Q3 FY26, it was −$0.06, down 155% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.32 | +14% |
| FY2024 | $0.28 | +17% |
| FY2023 | $0.24 | n/a |
| FY2022 | −$0.33 | n/a |
| FY2021 | −$0.15 | n/a |
| FY2020 | −$0.77 | n/a |
| FY2019 | −$0.24 | n/a |
| FY2018 | −$0.28 | −355% |
| FY2016 | $0.11 | −58% |
| FY2015 | $0.26 | +420% |
| FY2014 | $0.05 | n/a |
| FY2013 | −$0.04 | n/a |
| FY2012 | −$0.09 | n/a |
| FY2011 | −$0.14 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | −$0.06 | −155% | −$0.13 | |
| Q2 FY26 | −$0.10 | −267% | $0.04 | |
| Q1 FY26 | −$0.07 | −240% | $0.20 | |
| Q4 FY25 | $0.10 | +100% | $0.32 | |
| Q3 FY25 | $0.11 | +120% | $0.27 | |
| Q2 FY25 | $0.06 | −50% | $0.21 | |
| Q1 FY25 | $0.05 | −17% | $0.27 | |
| Q4 FY24 | $0.05 | −78% | $0.28 | |
| Q3 FY24 | $0.05 | −17% | $0.46 | |
| Q2 FY24 | $0.12 | +1100% | $0.47 | |
| Q1 FY24 | $0.06 | n/a | $0.36 | |
| Q4 FY23 | $0.23 | n/a | $0.24 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Mimedx's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MDXGMimedx | −$0.13 | −148% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| MOVMovado | $1.80 | +137% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| IRMDIradimed | $1.87 | +13% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| IARTIntegra Lifesciences | $0.17 | |
| BVSBioventus | $0.77 | +627% a year |
| PDEXPro DEX | $3.63 | +8% a year |
| STAAStaar Surgical | $0.07 | |
| Peer median | $1.27 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Mimedx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.